Webb Visit Slides
Kevin was kind enough to share his presentation with us from his visit this July: Here is the link on Owncloud: http://drive.bbe.23a.myftpupload.com/public.php?service=files&t=c3eceae62439a478b4d1b676924e45ee
Kevin was kind enough to share his presentation with us from his visit this July: Here is the link on Owncloud: http://drive.bbe.23a.myftpupload.com/public.php?service=files&t=c3eceae62439a478b4d1b676924e45ee
The retrial on cellulose (100kD) gold separations gave similar results to the first study (results from Tecan scans): particle salt results 5 0mM no au in filtrate, retentate concentration 15 0mM no au in filtrate 5 10mM no au in filtrate, retentate concentration 15 10mM no au in filtrate I took the membranes and rinsed…
I’ve been trying for a year now to make a nanofluidic transistor – a nanomembrane with a thin layer of metal coated in dielectric that allows for the dynamic modulation of the sieving characteristics of the chip. Beginning with the last 14 chips from wafer #1081, I coated them in ~3 nm of Ti and…
Using streaming potential data collected via the flow device Jess created, I have attempted to recreate the Zydney findings for membrane zeta potential. Ag/AgCl electrodes were used in 10mM KCl, mimicking identically the method outlined in Zydney. Data are below: The streaming potential for both trials of PES membranes varied significantly after 60 minutes in…
We still have plenty of things to do, but after five weeks working at the UR, we have come a long way: – Chip production for instructional use: done – Design and production of SU8 mold: done – Protocols for (@Fisher) manufacture of micro and milli (silhouette) fluidic devices: done – Construction and testing of chips…
In most of the images I’ve posted of bEnd3 on pnc-Si, it seemed like there were more cells crowded onto the free-standing pnc-Si compared to supported pnc-Si. This post shows that this is indeed true. To do cell counts, I stained cells with Hoechst 33342 (1uM in media) for 15 minutes @ room temperature and…
Introduction Currently, no FDA approved drug exist for the treatment of sepsis. Past sepsis pharmaceuticals attempted to target mediators of the innate immune response. These drugs, however, struggled to balance remedial immune suppression from complete immune knockdown in a patient population plagued my a maladative immune system. This fundamental issues is due in part to…